BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23381897)

  • 1. Defining prognostic factors of survival after external beam radiotherapy treatment of hepatocellular carcinoma with lymph node metastases.
    Chen YX; Zeng ZC; Fan J; Tang ZY; Zhou J; Zeng MS; Zhang JY; Sun J
    Clin Transl Oncol; 2013 Sep; 15(9):732-40. PubMed ID: 23381897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
    Zeng ZC; Tang ZY; Fan J; Qin LX; Ye SL; Zhou J; Sun HC; Wang BL; Wang JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1067-76. PubMed ID: 15913915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy.
    Zeng ZC; Fan J; Tang ZY; Zhou J; Wang JH; Wang BL; Guo W
    Cancer Sci; 2008 Dec; 99(12):2510-7. PubMed ID: 19032365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion.
    Hou JZ; Zeng ZC; Zhang JY; Fan J; Zhou J; Zeng MS
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):362-8. PubMed ID: 22381903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome.
    Xiang ZL; Zeng ZC; Fan J; Tang ZY; He J; Zeng HY; Chang JY
    Mol Biol Rep; 2012 Feb; 39(2):2021-9. PubMed ID: 21647551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma.
    Lee DY; Park JW; Kim TH; Lee JH; Kim BH; Woo SM; Kim SS; Lee WJ; Kim DY; Kim CM
    Strahlenther Onkol; 2015 Nov; 191(11):835-44. PubMed ID: 26174506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma.
    Kim K; Chie EK; Kim W; Kim YJ; Yoon JH; Lee HS; Ha SW
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):729-34. PubMed ID: 20171806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy for lymph node metastases from hepatocellular carcinoma.
    Toya R; Murakami R; Yasunaga T; Baba Y; Nishimura R; Morishita S; Nishi J; Beppu T; Baba H; Yamashita Y; Oya N
    Hepatogastroenterology; 2009; 56(90):476-80. PubMed ID: 19579624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic stratification and nomogram for survival prediction in hepatocellular carcinoma patients treated with radiotherapy for lymph node metastasis.
    Wee CW; Kim K; Chie EK; Yu SJ; Kim YJ; Yoon JH
    Br J Radiol; 2016 Sep; 89(1065):20160383. PubMed ID: 27416997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
    He J; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Wang JH; Sun J; Chen B; Yang P; Pan BS
    Cancer; 2009 Jun; 115(12):2710-20. PubMed ID: 19382203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.
    Zeng ZC; Fan J; Tang ZY; Zhou J; Qin LX; Wang JH; Sun HC; Wang BL; Zhang JY; Jiang GL; Wang YQ
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):432-43. PubMed ID: 15667964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for lymph node metastases in patients with hepatocellular carcinoma: retrospective study.
    Yamashita H; Nakagawa K; Shiraishi K; Tago M; Igaki H; Nakamura N; Sasano N; Siina S; Omata M; Ohtomo K
    J Gastroenterol Hepatol; 2007 Apr; 22(4):523-7. PubMed ID: 17376045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?
    Jiang W; Zeng ZC
    Oncology; 2013; 84 Suppl 1():69-74. PubMed ID: 23428862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy treatment of adrenal gland metastases from hepatocellular carcinoma: clinical features and prognostic factors.
    Zhou LY; Zeng ZC; Fan J; Chen B; Rao SX; He J; Yang P; Hou JZ; Wu ZF; Zhang JY; Hu Y
    BMC Cancer; 2014 Nov; 14():878. PubMed ID: 25421498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose and Location of Irradiation Determine Survival for Patients with Hepatocellular Carcinoma with Macrovascular Invasion in External Beam Radiation Therapy.
    Iwamoto H; Nomiyama M; Niizeki T; Shimose S; Shirono T; Nakano M; Satani M; Okamura S; Noda Y; Kamachi N; Sakai M; Suzuki H; Kuromatsu R; Ogo E; Abe T; Tanaka M; Koga H; Torimura T
    Oncology; 2019; 96(4):192-199. PubMed ID: 30650415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation.
    He J; Zeng ZC; Fan J; Zhou J; Sun J; Chen B; Yang P; Wang BL; Zhang BH; Zhang JY
    BMC Cancer; 2011 Nov; 11():492. PubMed ID: 22107882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients.
    Chen YX; Zeng ZC; Tang ZY; Fan J; Zhou J; Jiang W; Zeng MS; Tan YS
    BMC Cancer; 2010 Sep; 10():492. PubMed ID: 20840777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of external beam radiotherapy complementing incomplete transarterial chemoembolization for hepatocellular carcinoma.
    Park S; Yoon WS; Jang MH; Rim CH
    Int J Radiat Biol; 2020 Dec; 96(12):1541-1549. PubMed ID: 32990486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trial.
    Zeng ZC; Tang ZY; Yang BH; Fan J; Qin LX; Jiang GL; Zhou J; Sun HC; Cheng JM; Wang JH
    Hepatogastroenterology; 2004; 51(55):201-7. PubMed ID: 15011864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image-guided intensity-modulated radiotherapy improves short-term survival for abdominal lymph node metastases from hepatocellular carcinoma.
    Zhang H; Chen Y; Hu Y; Yang P; Wang B; Zhang J; Sun J; Zeng Z
    Ann Palliat Med; 2019 Nov; 8(5):717-727. PubMed ID: 31865732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.